Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

[Basic features of the ISUP prostate carcinoma Gleason grading system: a preliminary analysis].

Wang GW, Shen DH.

Zhonghua Nan Ke Xue. 2014 Jun;20(6):514-7. Chinese.

PMID:
25029856
2.
3.

SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.

Pierconti F, Martini M, Cenci T, Petrone GL, Ricci R, Sacco E, Bassi PF, Larocca LM.

Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1.

PMID:
28144985
4.

From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.

Samaratunga H, Delahunt B, Yaxley J, Srigley JR, Egevad L.

Scand J Urol. 2016 Oct;50(5):325-9. doi: 10.1080/21681805.2016.1201858. Epub 2016 Jul 14. Review.

PMID:
27415753
5.

Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.

Huang CC, Kong MX, Zhou M, Rosenkrantz AB, Taneja SS, Melamed J, Deng FM.

Am J Surg Pathol. 2014 Aug;38(8):1096-101. doi: 10.1097/PAS.0000000000000235.

PMID:
24832163
6.

International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.

Egevad L, Delahunt B, Srigley JR, Samaratunga H.

APMIS. 2016 Jun;124(6):433-5. doi: 10.1111/apm.12533.

PMID:
27150257
7.

The heterogeneous Gleason 7 carcinoma of the prostate: analyses of low and high grade (risk) carcinomas with criteria of the International Society of Urological Pathology (ISUP).

Helpap B, Ringli D, Shaikhibrahim Z, Wernert N, Kristiansen G.

Pathol Res Pract. 2013 Mar;209(3):190-4. doi: 10.1016/j.prp.2012.10.016. Epub 2013 Feb 15.

PMID:
23419692
9.

Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.

Delahunt B, Egevad L, Srigley JR, Steigler A, Murray JD, Atkinson C, Matthews J, Duchesne G, Spry NA, Christie D, Joseph D, Attia J, Denham JW.

Pathology. 2015 Oct;47(6):520-5. doi: 10.1097/PAT.0000000000000318.

PMID:
26325671
10.

Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy.

Faraj SF, Bezerra SM, Yousefi K, Fedor H, Glavaris S, Han M, Partin AW, Humphreys E, Tosoian J, Johnson MH, Davicioni E, Trock BJ, Schaeffer EM, Ross AE, Netto GJ.

PLoS One. 2016 Jan 5;11(1):e0146189. doi: 10.1371/journal.pone.0146189. eCollection 2016.

11.

Gleason and Fuhrman no longer make the grade.

Delahunt B, Egevad L, Samaratunga H, Martignoni G, Nacey JN, Srigley JR.

Histopathology. 2016 Mar;68(4):475-81. doi: 10.1111/his.12803. Epub 2015 Nov 16. Review.

PMID:
26266664
12.

Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.

Gottipati S, Warncke J, Vollmer R, Humphrey PA.

Am J Surg Pathol. 2012 Jun;36(6):900-7. doi: 10.1097/PAS.0b013e3182495dee.

PMID:
22367295
13.

Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial.

Lucia MS, Bostwick DG, Somerville MC, Fowler IL, Rittmaster RS.

Arch Pathol Lab Med. 2013 Dec;137(12):1740-6. doi: 10.5858/arpa.2012-0447-OA.

PMID:
24283854
14.

Prostate cancer: from Gleason scoring to prognostic grade grouping.

Montironi R, Santoni M, Mazzucchelli R, Burattini L, Berardi R, Galosi AB, Cheng L, Lopez-Beltran A, Briganti A, Montorsi F, Scarpelli M.

Expert Rev Anticancer Ther. 2016;16(4):433-40. doi: 10.1586/14737140.2016.1160780. Review.

PMID:
27008205
15.

Standardization of Gleason grading among 337 European pathologists.

Egevad L, Ahmad AS, Algaba F, Berney DM, Boccon-Gibod L, Compérat E, Evans AJ, Griffiths D, Grobholz R, Kristiansen G, Langner C, Lopez-Beltran A, Montironi R, Moss S, Oliveira P, Vainer B, Varma M, Camparo P.

Histopathology. 2013 Jan;62(2):247-56. doi: 10.1111/his.12008.

PMID:
23240715
16.

[The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

Kristiansen G, Egevad L, Amin M, Delahunt B, Srigley JR, Humphrey PA, Epstein JI; Graduierungskommittee.

Pathologe. 2016 Feb;37(1):17-26. doi: 10.1007/s00292-015-0136-6. German.

PMID:
26809207
17.

The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer.

Samaratunga H, Delahunt B, Gianduzzo T, Coughlin G, Duffy D, LeFevre I, Johannsen S, Egevad L, Yaxley J.

Pathology. 2015 Oct;47(6):515-9. doi: 10.1097/PAT.0000000000000315.

PMID:
26325670
18.

Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy.

Miyake H, Muramaki M, Furukawa J, Tanaka H, Inoue TA, Fujisawa M.

Urol Oncol. 2013 Nov;31(8):1511-6. doi: 10.1016/j.urolonc.2012.05.001. Epub 2012 May 31.

PMID:
22658882
19.

Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.

Minardi D, Mazzucchelli R, Scarpelli M, Massari F, Ciccarese C, Lopez-Beltran A, Cheng L, Montironi R.

Future Oncol. 2016 Jun;12(12):1431-3. doi: 10.2217/fon-2016-0113. Epub 2016 Mar 30. No abstract available.

20.

Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring?

Van Praet C, Libbrecht L, D'Hondt F, Decaestecker K, Fonteyne V, Verschuere S, Rottey S, Praet M, De Visschere P, Lumen N; Uro-Oncology Group Ghent.

Clin Genitourin Cancer. 2014 Jun;12(3):160-6. doi: 10.1016/j.clgc.2013.11.008. Epub 2013 Nov 12.

PMID:
24361055

Supplemental Content

Support Center